Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.71 USD | -4.56% | -16.60% | -37.71% |
22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
07/05 | Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.71% | 98Cr | |
+9.99% | 11TCr | |
+12.01% | 11TCr | |
-3.07% | 2.22TCr | |
-0.67% | 2.13TCr | |
-4.64% | 1.88TCr | |
-6.90% | 1.75TCr | |
-39.36% | 1.72TCr | |
+5.82% | 1.41TCr | |
+33.05% | 1.22TCr |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Transcript : Scholar Rock Holding Corporation Presents at Morgan Stanley 17th Annual Global Healthcare Conference, Sep-11-2019 11